Global Nanoparticle Drug Delivery Market: Dosage, Price and Clinical Pipeline Outlook to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028” report has been added to ResearchAndMarkets.com’s offering. During the last few decades, there has been enormous development in the field of delivery systems to provide therapeutic agents or natural based active compounds to the target location for the management of several … [Read more…]

Amal Tamara by Award-winning Tamara Leisure Experiences Launched in Kerala With Resounding Success

Where the balance of mind, body, and spirit is restored through the ancient and time-tested tenets of Ayurveda KERALA, India–(BUSINESS WIRE)–The newly-launched Amal Tamara in Alleppey, Kerala, is Tamara Leisure Experiences’ first foray into luxury wellness Ayurveda experiences. This 19-key property continues to hold the company’s core values of Responsible Hospitality at the root of … [Read more…]

Worldwide Hand Sanitizer Industry to 2029 – The Market Evidenced an Exponential Growth of About 600% YOY from 2019 to 2020 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hand Sanitizer Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029” report has been added to ResearchAndMarkets.com’s offering. Hand sanitizer which was largely used in North America that accounted for almost 45% of market revenues precovid, has become a household product in Asia … [Read more…]

Adamas publishes new data analyses demonstrating GOCOVRI treatment more than doubled ON time without dyskinesia in patients with Parkinson’s disease

— Patients enrolled in the pivotal trials increased daily ON time without dyskinesia by 2.9 hours with GOCOVRI compared to placebo, through the reduction of both OFF time and dyskinesia – — GOCOVRI is the first and only therapy for the treatment of OFF and/or dyskinesia for patients with Parkinson’s disease on levodopa-based therapy – … [Read more…]

Global Chronic Myeloid Leukemia (CML) Treatment Market to 2029 – Featuring Novartis, Bristol-Myers Squibb and Pfizer Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Chronic Myeloid Leukemia (CML) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2019 to 2029” report has been added to ResearchAndMarkets.com’s offering. The report provides detailed intelligence about the chronic myeloid leukemia (CML) treatment market. The report includes detailed analysis on market dynamics, market … [Read more…]

Medsenic Announces Positive Results of its Phase II Clinical Study with Arscimed® for the Treatment of Chronic Graft Versus Host Disease (cGvHD)

Arscimed® (arsenic trioxide) reaches an impressive 75% clinical efficacy at 6 months when administered intraveinously over one month to moderate to severe cGvHD patients Primary efficacy endpoint met: complete or partial disease remission at 6 months and sustained response at 12 months Very significant reduction in corticosteroid use STRASBOURG, France–(BUSINESS WIRE)–Medsenic, a clinical stage biopharmaceutical … [Read more…]

Dr. Kade ranks 3rd in the Pharma Trend Ranking 2020

Dr. Kade is ranked 3rd in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large Individual, Medium-sized and International Companies”. The latest new launch and candidate for the award “The Most Innovative Product” 2021 in the OTC category is the wash lotion KadeFemin®, which contains moisturising hyaluronic acid as well as a … [Read more…]

Bionorica ranks second in the Pharma Trend Ranking 2020

Bionorica is ranked second in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large individual, medium-sized and international companies”. In addition, Bionorica wins the pharmacists’ award “The Golden Tablet” in the OTC category.

Dr. Falk Pharma ranks 4th in the Pharma Trend Ranking 2020

Dr. Falk Pharma is ranked 4th in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large individual, medium-sized and international companies”. In Pharma Trend, Dr. Falk Pharma was recognised for innovation for the last time in 2018 with Jorveza®, which was awarded “The Most Innovative Product” by gastroenterologists in the OD category.

Grünenthal ranks 10th in Pharma Trend Ranking 2020

Grünenthal is ranked 10th in the multispecialty ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large Individual, Medium-sized and International Companies”. In Pharma Trend, Grünenthal was awarded for innovation for the first time in 2020 with Palexia®, which received the award “The Most Innovative Product” in the Rx category from pain therapists.